000 01181 a2200337 4500
005 20250512080953.0
264 0 _c19851213
008 198512s 0 0 eng d
022 _a0267-0623
024 7 _a10.1136/bmj.291.6503.1155
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWilliams, G
245 0 0 _aTreatment with danazol and plasma glucagon concentration.
_h[electronic resource]
260 _bBritish medical journal (Clinical research ed.)
_cOct 1985
300 _a1155-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aDanazol
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aGlucagon
_xblood
650 0 4 _aGlucose Tolerance Test
650 0 4 _aHumans
650 0 4 _aInsulin
_xblood
650 0 4 _aLupus Erythematosus, Systemic
_xblood
650 0 4 _aPregnadienes
_xtherapeutic use
700 1 _aLofts, F
700 1 _aFuessl, H
700 1 _aBloom, S
773 0 _tBritish medical journal (Clinical research ed.)
_gvol. 291
_gno. 6503
_gp. 1155-6
856 4 0 _uhttps://doi.org/10.1136/bmj.291.6503.1155
_zAvailable from publisher's website
999 _c3937518
_d3937518